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Abstract 
The integration of additive manufacturing (AM) technology within biological systems holds 
significant potential, specifically when refining the methods utilised for the creation of in vitro models. 
Therefore, examination of cellular interaction with the physical/physico-chemical properties of 3D 
printed polymers is critically important. In this work, skeletal muscle (C2C12), neuronal (SH-SY5Y) 
and hepatic (HepG2) cell lines were utilised to ascertain critical evidence of cellular behaviour in 
response to 3D printed candidate polymers; Clear-FL (stereolithography, SL), PA-12 (laser sintering, 
LS) and VeroClear (PolyJet). This research outlines initial critical evidence for a framework of 
polymer/AM process selection when 3D printing biologically receptive scaffolds, derived from 
industry standard, commercially available AM instrumentation. C2C12, SH-SY5Y and HepG2 cells 
favoured LS polymer PA-12 for applications in which cellular adherence is necessitated. However, 
cell type specific responses were evident when cultured in the chemical leachate of photo-polymers 
(Clear-FL and VeroClear). With the increasing prevalence of 3D printed bio-interfaces, the 
development of rigorous cell type specific biocompatibility data is imperative. Supplementing the 
currently limited database of functional 3D printed biomaterials affords the opportunity for 
experiment-specific AM process and polymer selection, dependent on biological application and 
intricacy of design features required. 
Key Words: 3D Printing; Skeletal Muscle; Neuronal; Hepatocyte; Biocompatibility. 
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1. Introduction  
The possibility of three-dimensional (3D) printing (also known as Additive Manufacturing) bespoke 
biologically receptive parts, has driven the increasing application of Additive Manufacture (AM) 
technologies in biological systems. Techniques such as Fused Deposition Modelling (FDM),[1] photo-
polymerisation processes such as stereolithography (SL)[2,3] and PolyJet printing, in addition to 
powder-based particle consolidation laser sintering (LS)[4] technology have all previously been 
utilised to provide devices/scaffolds for bioengineering.[5–11] However, the numerous advantages of 
AM, including design freedom and rapid production without moulds or tooling, are currently offset by 
a lack of fully characterised biocompatible materials.[12,13]  
FDM affords a variety of biocompatible polymers with the capability to control and influence cellular 
phenotype,[14] however such compatibility is, in part, negated when geometries with design features of 
increasing complexity are required. Despite being the most widely used, inexpensive and readily 
available 3D printing process, the diverse application of AM across scientific disciplines has elicited a 
trend toward the commercialisation of alternative processes capable of manufacturing such advanced 
geometries. SL and jetting based printing afford the capability to produce sophisticated designs, 
however the chemical complexity of the photo-sensitive resins typically result in non-biocompatible 
parts.[15] These devices typically require time-consuming polymer surface modification in order to 
facilitate cellular compatibility.[16] Comparable design complexities are attainable when printing with 
LS, however the accessibility of such technology has previously been commercially limited. Despite 
recent developments in the commercialisation of 3D printing technology toward user-friendly desktop 
appliances, investigations detailing the biocompatibility of useable polymers remain scarce. As such, 
the development of a wide-ranging knowledge base of AM candidate polymers derived across a range 
of advanced 3D printing processes remains imperative.[17]  
Favourable candidate polymers for biological integration often require commercially available and 
accessible resins of transparent/clear appearance, to enable the visualisation of cellular samples within 
engineered devices. Polymers such as SL desktop appliance FormLabsTM Clear-FLGPCL02 resin and 
PolyJet VeroClear-RGD810 resin, which can form optically transparent structures, satisfy the criteria. 
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In addition, biologically amenable candidate Nylon-6 polymers[18] have previously been documented, 
outlining the applicability of LS polyamide-12 (PA-12) when fabricating biocompatible devices.[19] 
3D printed biocompatible polymers hold significant importance for tissue and biochemical 
engineering applications, with the methods required to construct the models that examine highly 
complex cellular physiological processes currently being revolutionised by AM.[6,20–27] Pertinent to 
this are tissue engineered in vitro models,[28–31] designed to replicate the in vivo cellular and molecular 
mechanisms that regulate musculoskeletal[32] and neuromuscular disorders.[33] As such, defining the 
compatibility of mammalian cells frequently used within these models; C2C12 murine skeletal 
myoblasts[34] and SH-SY5Y neuroblastoma[35] human derived cell lines are of particular relevance. 
This is primarily due to the lack of availability of primary tissue, and their capability to afford 
physiologically representative in vitro models of native human in vivo tissues. Human derived HepG2 
hepatocellular carcinoma[36] cell line also holds significant importance due to their use within 
pharmaceutical toxicity assessments. Cytochrome P450 enzymes are of specific interest within 
toxicology research,[37–39] due to their central role in drug metabolism[40], outlining the necessity for 
their inclusion within this research. 
Due to the diverse range of printed devices within biological systems, it is of paramount importance to 
comprehend both the indirect and direct effects of 3D printable polymers. As such, this investigation 
sought to determine the direct (cells cultured directly on the polymer) and indirect (cells cultured in 
chemical leached medium) effect of three commercially available 3D printable polymers across three 
sophisticated AM processes. SL: Clear FLGPCL02 (FormLabs GmbH), PolyJet: VeroClear-RGD810 
(Stratasys) and LS: PA2200 (which is a polyamide-12 PA-12, EOS GmbH) on C2C12, SH-SY5Y and 
HepG2 cellular compatibility.   
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2. Materials and Methods 
2.1. 3D Printing and Sample Preparation 
3D printing was undertaken utilising the following processes and parameters: FormLabs Form 2TM 
machine using the clear resin FLGPCL02 set at 0.1 mm layer thickness. Stratasys Objet Connex 
500TM using the VeroClear-RGD810 material (with SUP705 support material) set at 0.33 mm layer 
thickness and default speed/quality settings. EOS Formiga P100TM using EOS PA2200 powder (PA-
12) at 0.1 mm layer thickness. 3D CAD modelling was performed using Siemens NX software (v8.5, 
Siemens) with completed .stl files verified using Materialise MiniMagics (Materialise NV). 
Completed .stl files were processed using manufacturer recommended software for each process.  
Clear FLGPCL02 (Clear-FL) samples were removed from the build plate and cleaned in isopropanol 
to remove uncured resin, prior to being submersed and agitated in 70% industrial methylated spirit 
(IMS) for ≤ 30 mins. VeroClear-RGD810 (VeroClear) and PA-12 samples were removed from build 
plates and cleaned using a soft abrasive brush to remove supports and un-sintered powder respectively. 
All samples were sterilised via UV for ≥ 1 h, prior to being adhered to culture well plates using an in-
house bio-adhesive (aquarium glue) that has been found to be biocompatible.[14] Once adhered, 
samples were rinsed with 70% IMS and left for remaining liquid to evaporate, prior to being further 
treated with 1x phosphate buffered saline (PBS). Prior to experimental treatment, Clear-FL and 
VeroClear samples (preconditioned by the same processing steps as the final intended product) were 
exposed to 10 days incubation within static growth medium (5 ml, supplementary material Figure. S1) 
at 37 ºC to facilitate the withdrawal of potentially harmful chemical leachate from sample scaffolds. 
Each sample scaffold disc (30 mm Ø x 1 mm thick, surface area ~ 15cm2) provided a 3cm2 per ml 
surface area to volume ratio and was designed to cover most of the culture area of a six-well plate. 
Where suitable, the methodology was devised with the international standards organisation (ISO 
10993) guidelines taken into consideration (Table S1, supplementary material).  
2.2. Cell Culture 
C2C12 murine skeletal myoblasts, all below passage 9, were cultured in T80 flasks (Nunc™, Fisher 
Scientific, UK) in growth medium (GM); composed of 79 % DMEM (Sigma), 20 % FBS (Pan 
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Biotech) & 1 % penicillin-streptomycin (Fisher) until 80 % confluence was obtained. Incubated cells 
GM was changed every 24 h during the 72 h culture period, prior to transfer into differentiation 
medium (DM); 97 % DMEM, 2 % horse serum (Sigma) & 1 % penicillin-streptomycin for 120 h. 
C2C12 cell DM was changed once after 72 h, prior to remaining in culture for a further 48 h. The SH-
SY5Y neuroblastoma cell line was cultured in T80 flasks in GM; 89 % Glutamax (Sigma, UK) 10 % 
FBS, 1 % penicillin-streptomycin until 80 % confluence was attained, prior to being harvested for 
experimental usage. SH-SY5Y cells were cultured for 48 h in GM prior to inducing neuronal 
differentiation via medium (DM) containing 10 µM retinoic acid (Sigma, UK) differentiating agent 
for 72 h. HepG2 cells were cultured in T225 flasks (Nunc™, Fisher Scientific, UK) in GM; 88 % 
Earls modified Eagles Medium (MEM, Sigma, UK), 10 % FBS, 1 % penicillin-streptomycin and 1 % 
non-essential amino acids (NEAA, Sigma, UK) until 60 % confluence was obtained, at which point 
cells were harvested for experimental treatments spanning 96 h. HepG2 and SH-SY5Y mediums were 
changed every 24 h with all experimental cells below passage 6. All cell lines were obtained from 
ECACC and incubated at 5 % CO2 atmosphere and 37 °C (HERAcell 240i, Thermo Fisher, UK) for 
the duration of all experiments. 
2.3. Experimental Treatments 
Experiments were designed to simultaneously assess critical evidence of cellular viability, 
morphological observations and cell line specific phenotype characterisation, in response to the direct 
(cells cultured directly on the polymer) and indirect (cells cultured within chemical leachate) effects 
of each polymer. 3D printed samples were used to evaluate the direct (n=2) and indirect (n=2) 
biocompatibility of each polymer per repeat (n=3). Experiments generated n=6 per condition, totalling 
n=12 per analyses at each specific time-point, derived from n=3 experimental repeats. This protocol 
was completed separately for each cell line (C2C12, SH-SY5Y and HepG2).  
To assess direct biocompatibility, 1 x 105 (C2C12, HepG2) or 1 x 104 (SH-SY5Y) cells were seeded 
either directly onto the 3D printed discs that had been adhered to wells and left for ≥ 1 h to allow for 
initial cellular adhesion, or to control (CON) wells. Once attached, 2 ml GM was added to each well. 
To assess the indirect biocompatibility of chemical leachate from each polymer, 3D printed discs were 
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attached to the culture area of two wells that were acellular, containing only medium (MEDIA 
ONLY). Chemically leached medium was then transferred to its corresponding experimental well 
during each repeat, ensuring that cellular medium was directly representative of either cumulative 
polymer degradation or CON at each specific time-point. Each MEDIA ONLY well was pre-
incubated with 2 ml GM for 24 h prior to commencing each experiment, to ensure cells were seeded 
within media that had been exposed to the chemical leachate of each polymer. Medium, once 
transferred to experimental wells, was replenished for further 24 h incubation prior to each subsequent 
media change. During the last 24 h in which the cells were cultured in GM, DM was added to the 
MEDIA ONLY wells in preparation to induce differentiation in C2C12 and SH-SY5Y cell cultures.  
Cells were analysed for cell viability at cell line specific time-points and fixed for fluorescence 
imaging at DM120 h (C2C12), DM72 h (SH-SY5Y) and GM96 h (HepG2) time-points. After 
concluding cellular viability analysis at experimental termination, cells were washed twice with 2 ml 
PBS, prior to RNA isolation with cells being immersed and homogenised in 0.5 ml TRIzol per well.  
2.4. Fluorescence Staining and Microscopy 
Cells were washed twice in 2 ml PBS per well, fixed (3.7 % Paraformaldehyde) and permeabilised 
(Triton X-100, Fisher, 1:500). C2C12 cells were stained using ƒ-actin molecular probe rhodamine 
phalloidin (1:200; Life Technologies, Molecular Probes) for ≥ 1 h. SH-SY5Y and HepG2 cells were 
blocked 5% goat serum for 30 mins, labelled with monoclonal mouse anti-β-tubulin III (1:200; Sigma, 
UK) and Anti-Human Serum Albumin (ab10241) antibodies (1:100; Abcam, UK) respectively for ≥ 2 
h prior to being counterstained with AlexaFluor®488-conjugated goat anti mouse IgG (1:200; Life 
technologies, Thermo Scientific) secondary fluorochrome for ≥ 1 h. DAPI nuclear stain (1:2000; Life 
Technologies, Molecular Probes) was used to stain nuclei in all cell lines. Rhodamine phalloidin was 
excited at 540 nm and emitted at 565 nm and appears red in fluorescence images. Alexa Fluor® 488 
appears green and is indicative of tubulin (SH-SY5Y) or albumin (HepG2) expression at standardised 
exposures. DAPI was excited at 358 nm and emitted at 461 nm and appears blue.  
Light micrographs were captured on a Leica DMIL LED Light Microscope. Fluorescence images 
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were visualised using a Leica DM2500 fluorescence microscope (20x) with manufacturer’s software 
(Leica Application Suite X). Images were analysed using IMAGE J 1.50a/Fiji (Java 1.6.0_24) 
software (National institute of Health, Bethesda, MD, USA). Image inclusion criteria were set at ≥ 5 
images per well. Myotube inclusion criteria were defined as containing ≥ 3 nuclei per myotube. 
Cumulative frequencies were calculated to determine the number of measures required per myotube, 
in addition to the number of myotubes and neurites necessitated per image for each analysis. Analysis 
of nuclei number was performed using an in-house macro instruction designed for Fiji (Java 1.6.0_24) 
image analysis software (Image J 1.50a).  
2.5. Cell Viability alamarBlue® Assay 
Cellular viability reagent; alamarBlue® diluted 1:10 DMEM (C2C12), Glutamax (SH-SY5Y) or MEM 
(HepG2) was used to assess cell viability and proliferation in C2C12 and SH-SY5Y at 72 and 120 h 
experimental time-points. HepG2 cells were analysed every 24 h across the 96 h culture period. Cells 
were washed twice with 2 ml PBS prior to being treated with 2 ml per well alamarBlue® stock 
solution and humidified 5 % CO2 at 37 °C for 4 h. 100 μl per well of solution was then added to a 
black well 96-well plate and analysed for fluorescence intensity. Increased fluorescence of 
alamarBlue® reagent is indicative of an increase in cellular viability. alamarBlue® fluorescence 
signal was excited at 540-570 nm (peak excitation: 570 nm) and emitted at 580-610 nm (peak 
emission: 585 nm).  
2.6. RNA extraction and Quantitative RT-PCR  
RNA was extracted using the TRIzol method, according to manufacturer’s instructions (Sigma). RNA 
concentration and purity were obtained by UV spectroscopy at optical density (ODs) of 260 and 280 
nm using a Nanodrop 2000 (Fisher, Rosklide, Denmark). All RNA samples were analysed in 
duplicate. Twenty nanograms of RNA were used per RT-PCR paired species-specific reaction for 
RPII- β and MYH3 (C2C12), two nanograms for RPII- β and MAPT (SH-SY5Y) and two nanograms 
for RPII- β, CYP1A1, 1A2, 2D6 and 3A4 (HepG2, Table 1). All mRNA expression of cells cultured 
within direct/indirect polymer conditions is normalised to that of control, hence responses above or 
below control values are indicative of increased or decreased gene transcription. 
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RT-PCR amplifications were carried out using Power SYBR Green RNA-to-CT 1 step kit (Qiagen) on 
a ViiATM Real-Time PCR System (Applied bio-systems, Life Technologies), analysed using ViiATM 
7RUO Software. RT-PCR procedure was as follows: 50 °C, 10 min (for cDNA synthesis), 95 °C, 5 
min (transcriptase inactivation), followed by 95 °C, 10 sec (denaturation), 60 °C, 30 sec 
(annealing/extension) for 40 cycles. Relative gene expression was calculated using the comparative 
CT (ΔΔCT) equation for normalised expression ratios; relative expression calculated as 2-ΔΔCT, where 
CT is representative of the threshold cycle.[41] RPII-β was used as the housekeeping gene in all RT-
PCR assays. To compare conditions, one control sample from each experimental repeat (n=3) per cell 
type was used as the calibrator condition in the CT (ΔΔCT) equation. RT-PCR data is presented as 
relative gene expression level, determined by the ΔΔCT equation.  
Table 1  
Primers utilised for examination of C2C12, SH-SY5Y and HepG2 mRNA. (m) – Mouse, (h) - Human.  
Target mRNA Primer Sequence (5'-3') Product Length NCBI Reference Sequence 
RPII-β (m) 
F: GGTCAGAAGGGAACTTGTGGTAT 
197 NM_153798.2 
R: GCATCATTAAATGGAGTAGCGTC 
MYH3(m) 
F:  CATATCAGAGTGAGGAGGAC 
86 NM_001099635.1 
R: CTTGTAGGACTTGACTTTCAC 
RPII-β (h) 
F: AAGGCTTGGTTAGACAACAG 
142 NM_000938.2 
R: TATCGTGGCGGTTCTTCA 
MAPT (h) 
F: GAAAAATAGGCCTTGCCTTAG 
170 XM_005257371.4 
R: CCTTGAGTTTCATCTCCTTTG 
CYP1A1(h) 
F: CATTAACATCGTCTTGGACC 
114 NM_001319217.1 
R: TCTTGGATCTTTCTCTGTACC 
CYP1A2 (h) 
F: CACTATCAGGACTTTGACAAG 
119 NM_000761.4 
R: AGGTTGACAATCTTCTCCTG 
CYP2D6 (h) 
F:  CTGGCAGAGATGGAGAAG 
146 XM_017030331.1 
R: TGTAGGATCATGAGCAGG 
CYP3A4 (h) 
F: AGTCTTTCCATTCCTCATCC 
129 XM_017011780.1 
R: TGCTTTTGTGTATCTTCGAG 
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2.7. Statistical analysis  
Statistical analyses and significance of data were determined using IBM© SPSS© Statistics version 23. 
Mauchly’s test of sphericity and Shapiro-Wilk tests were used to confirm homogeneity of variance 
and normal distribution of data respectively. Where parametric assumptions were met, a 4 x 2 (SH-
SY5Y & C2C12) and 4 x 4 (HepG2) ANOVA was used for alamarBlue® analyses. One-way ANOVA 
(1 x 4) was used to analyse mRNA expression and morphological data; myotube number, myotube 
width, fusion index, nuclei number and neurite length only concerned with experimental termination 
time-points. Where significant interactions were observed, Bonferroni post-hoc analyses were used to 
analyse differences between conditions at specific time-points. Non-parametric Kruskal-Wallis (H) 
analysis was undertaken where data violated parametric assumptions. Mann-Whitney (U) tests were 
then utilised to determine significance between conditions, in accordance with Bonferroni correction 
to account for incremental type-1 error. All data is reported as mean ± standard deviation (SD). 
Significance was assumed at P ≤ 0.05. 
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3. Results 
3.1. C2C12   
3.1.1. Cell Viability 
Cellular viability of C2C12 skeletal myoblasts cultured on 3D printed polymer scaffolds was 
significantly impaired across all conditions after GM72 h (Figure. 1 A, Clear-FL; P = 0.002, 
VeroClear; P =0.002, PA-12; P = 0.002) compared to control, outlining reduced rates of proliferation 
at this time-point. Despite reductions compared to control, cells cultured on VeroClear displayed 
significantly higher levels of metabolic activity compared to 3D printed Clear-FL (P = 0.002) and PA-
12 (P = 0.002) polymers, outlining preferential cell proliferative characteristics of this polymer 
scaffold compared to those derived from LS and SL processes. This response was in-part replicated 
after DM120 h time-points, with significantly diminished metabolic activity evident in Clear-FL (P = 
0.002), VeroClear (P = 0.009) and PA-12 (P = 0.004) compared to control conditions. VeroClear 
displayed potentiated viability compared to Clear-FL (P = 0.002), however PA-12 cellular activity 
recovered to comparable levels. Significantly, reductions in viability documented in direct polymer 
conditions were completely ablated after GM72 and DM120 h in cells cultured in polymer chemical 
leachate, demonstrating comprehensive recovery of cellular viability within both proliferative and 
myogenic phases. Despite significantly potentiated metabolic activity observed in Clear-FL conditions 
when compared to VeroClear (P = 0.004) after DM120 h, it is reasonable to assert that cells cultured 
within chemical leachate maintained a viable phenotype across polymers, due to the homogeneity of 
metabolic activity observed when compared to control conditions.  
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Figure.1. Cellular Viability of C2C12 cultured on (A) and within chemical leachate (B) of 3D printed polymers; Clear-
FLGPCL02 (Clear-FL), PA-12 and VeroClear-RGD810 (VeroClear) at GM72 and DM120 h time-points. Significantly 
different from * control, $ Clear-FL and # VeroClear. ** P ≤ 0.01. 
3.1.2. C2C12 Morphology 
C2C12 cells displayed significant morphological reductions in myotube number (Figure.2 B) when 
cultured directly on 3D printed Clear-FL (P = 0.009) and VeroClear (P = 0.010) polymer scaffolds. 
Non-significant reductions were observed in cells cultured on PA-12 scaffolds, outlining cellular 
preference for this polymer in comparison to photo-polymerisation centric polymer conditions, due to 
homogeneous myotube widths documented in Clear-FL, PA-12 and VeroClear conditions (Figure. 2 
D). Fusion index analyses (Figure. 2 F) further supports this assertion, with reductions in fused nuclei 
evident in C2C12 cultured on VeroClear scaffolds compared to control (P ≤ 0.0005) and PA-12 (P = 
0.003). Reductions in myotube number (Figure. 2 C) were also documented in cells cultured in 
VeroClear chemical leachate compared to control (P = 0.002). Despite homogeneous myotube widths 
being evident between all conditions (Figure. 2 E), fusion index analyses outlined inhibited nuclear 
fusion in VeroClear chemical leachate conditions when compared to control (P = 0.013), suggesting a 
potential inhibitory effect on the myogenic differentiation of C2C12 cells when interacting with the 
chemical parameters of this polymer (Figure. 2 G).  
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Figure.2. (a) Morphological staining of the actin cytoskeleton (red) and nucleic DNA (blue) of C2C12 cultured on (direct) and 
within chemical leachate (indirect) of 3D printed polymers; Clear-FLGPCL02 (Clear-FL), PA-12 and VeroClear-RGD810 
(VeroClear) at DM120 h time-points. (b) Indirect and (c) direct myotube number. (d) Indirect and (e) direct myotube width. 
Fusion Index of C2C12 cultured in chemical leachate (f) and directly on (g) 3D printed polymers after DM120 h. Fusion 
index could not be determined for Clear-FL due to this polymer displaying high auto-fluorescence in response to multiple 
nuclear fluorochromes. Significantly different from * control and Ψ PA-12. ** P ≤ 0.01, *** P ≤ 0.0005. Scale bars = 100 
µm. 
3.1.3. C2C12 MYH3 mRNA Expression 
Significant decreases in MYH3 (Figure.3), the embryonic heavy chain predominantly expressed 
within two dimensional skeletal muscle cultures,[42] were documented in C2C12 cells cultured on 3D 
printed Clear-FL (P = 0.010) and VeroClear (P = 0.002) scaffolds. In addition, significant reductions 
were evident between VeroClear and PA-12 scaffolds (P = 0.004), outlining the biocompatibility of 
this polymer. Reduced expression observed within Clear-FL and VeroClear direct conditions was in-
part ameliorated from 7 % to 60 % and 49 % of control MYH3 expression respectively when cultured 
within chemical leachate of these polymers, however these differences remained significant (P = 
0.010, P = 0.002). Although comparable MYH3 transcription was documented in direct PA-12 
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scaffold cultures, this expression was significantly reduced compared to control in chemical leachate 
conditions (P = 0.002).  
 
Figure.3. MYH3 expression of C2C12 cultured on (A) and within chemical leachate (B) of 3D printed polymers; Clear-
FLGPCL02 (Clear-FL), PA-12 and VeroClear-RGD810 (VeroClear) at DM120 h time-points. Significantly different from * 
control and Ψ PA-12. ** P ≤ 0.01, *** P ≤ 0.0005.  
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3.3. SH-SY5Y  
3.3.1. Cell Viability 
SH-SY5Y metabolic activity (Figure. 4 B and C) was significantly reduced when cells were cultured 
on Clear-FL (P = 0.002) and VeroClear (P = 0.009) scaffolds compared to control, outlining inhibition 
of proliferation in response to physico-chemical and chemical characteristics of these polymers. This 
response remained consistent during the differentiation phase, with reduced viability observed in 
Clear FL (P = 0.002) and VeroClear (P = 0.002) compared to control. Continuous cellular replication 
was also evident within PA-12 conditions compared to Clear-FL (P = 0.004), outlining viable 
proliferative cultures of SH-SY5Y cells on this polymer scaffold. Reduced viability in VeroClear 
scaffolds was ameliorated in chemical leachate conditions after GM48 h, however this response was 
not replicated in Clear-FL conditions, which remained significantly less metabolically active 
compared control (P = 0.002), VeroClear (P = 0.002) and PA-12 (P = 0.002). Viable cultures were 
again evident in VeroClear and PA-12 chemical leachate conditions after DM72 h, however Clear-FL 
SH-SY5Y cell cultures remained significantly less viable than control (P = 0.002) and PA-12 (P = 
0.002). 
3.3.2. SH-SY5Y Morphology 
Significantly potentiated neurite axonal extension (Figure. 4 E) was observed in Clear-FL (P = 0.002) 
and VeroClear (P = 0.004) chemical leachate conditions when compared to control, with Clear-FL 
eliciting the longest neurites in culture compared to VeroClear (P = 0.002) and PA-12 (P = 0.002). 
Despite eliciting greater neurite lengths in culture, Clear-FL also displayed significantly reduced 
nuclei number (Figure. 4 D) compared to control (P = 0.015) and VeroClear (P = 0.002), 
corresponding with the reduced metabolic activity documented in this condition. Tubulin could not be 
presented in direct conditions due to high auto-fluorescence evident in response to the Alex-Fluor488 
fluorochrome, with Clear-FL also highly auto-fluorescent in response to multiple nuclear fluorescent 
stains. 
3.3.3. SH-SY5Y MAPT mRNA Expression 
MAPT expression remained consistent across 3D printed polymer scaffolds in direct conditions 
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(Figure. 4 F); however, transcription levels of this gene could not be determined for Clear-FL due to 
the low cell numbers that remained on the scaffold at DM72 h time-points. Potentiated expression of 
this gene was however evident in VeroClear conditions when compared to control (P = 0.020) and 
Clear-FL (P = 0.039), outlining significantly enhanced axonal development in SH-SY5Y cells 
cultured within the chemical leachate of this polymer (Figure.4 G). 
 
Figure.4. (a) Morphological staining for tubulin (green) and nucleic DNA (blue) of SH-SY5Y cells cultured in chemical 
leachate of 3D printed polymers; Clear-FLGPCL02 (Clear-FL), PA-12 and VeroClear-RGD810 (VeroClear). Cellular 
viability of SH-SY5Y cultured on (b) and within chemical leachate (c) of 3D printed polymers at GM48 and DM72 h time-
points. Nuclei number (d) and neurite length (e) of SH-SY5Y cultured in chemical leachate of 3D printed polymers. MAPT 
expression of SH-SY5Y cultured on (f) and within chemical leachate (g) of 3D printed polymers at DM120 h time-points. 
Significantly different from * control, Ψ PA-12, $ Clear-FL and # VeroClear. * P ≤ 0.05, ** P ≤ 0.01.  
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3.4. HepG2 
3.4.1 Cell Viability 
HepG2 cells displayed diminished viability (Figure. 5 A) after 24, 48, 72 and 96 h in culture on Clear-
FL and VeroClear scaffolds compared to control and PA-12 (P ≤ 0.0005), with reduced metabolic 
activity also evident in Clear-FL compared to VeroClear (24; P ≤ 0.0005, 48; P ≤ 0.0005, 72; P = 
0.001, 96; P = 0.007). Increasingly higher levels of viability were observed in PA-12 scaffolds, 
however this decrement remained significant compared to control conditions (24; P = 0.008, 48; P = 
0.008, 72; P = 0.001, 96; P = 0.007). Diminished viability reported in direct conditions was rescued in 
chemical leachate PA-12 conditions, however remained significantly reduced at intermediate time-
points in VeroClear conditions (48; P = 0.037, 72; P = 0.023) and consistently throughout Clear-FL 
leachate cell cultures (24; P = 0.033, 48; P ≤ 0.0005, 72; P ≤ 0.0005, 96; P = 0.003) despite 
biologically relevant phenotypic restoration (Figure. 5 B). In addition, PA-12 HepG2 cells displayed 
significantly potentiated metabolic activity compared to Clear-FL at 48 (P = 0.003) and 72 h (P = 
0.014) time-points further outlining cellular preference for this polymer.  
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Figure.5. Metabolic activity of HepG2 cells cultured on (a) and within chemical leachate (b) of 3D printed polymer scaffolds; 
Clear-FLGPCL02 (Clear-FL), PA-12 and VeroClear-RGD810 (VeroClear). Nuclei number of HepG2 cells cultured on (c) 
and within chemical leachate (d) of 3D printed polymers. (a and b * Significance within time-point P ≤ 0.01). Significantly 
different from * control. * P ≤ 0.05, ** P ≤ 0.01.  
3.4.2. HepG2 Morphology 
The metabolic activity of HepG2 cells cultured directly on polymer scaffolds demonstrated 
correlation with nuclear number (Figure. 5 C) evident after 96 h in culture, with significant 
decrements observed in VeroClear (P = 0.002) conditions at this time-point. However, the reduced 
nuclei number in HepG2 cultured on PA-12 (P = 0.002) polymer scaffold appears to be a result of 
microscopic distortion; with cells co-existing amongst nylon particles at different ranges in the Z axis 
(Figure. 6 A), hence producing misrepresentative nuclear counts per image frame dependent on focal 
plane. Significant reductions were also documented in HepG2 nuclei when cultured in chemical 
leachate of Clear-FL (P = 0.015) compared to control, outlining potential chemical inhibition of 
proliferation in response to this polymer (Figure. 5 D).  
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3.4.3 HepG2 Cytochrome P450 mRNA Expression 
HepG2 cytochrome P450 CYP1A1 mRNA expression was significantly up regulated in Clear-FL (P = 
0.006) and VeroClear (P = 0.017) direct polymer scaffold conditions (Figure.6 C), however 
potentiated HepG2 CYP1A2 and CYP2D6 transcription remained isolated to Clear-FL (P = 0.016), 
VeroClear conditions (P = 0.001) respectively, outlining increases in the mechanisms associated with 
detoxification. Such increases in expression observed in direct polymer conditions, were completely 
ablated in the CYP1A1 and 2D6 enzymatic gene expression levels when cultured in chemical leachate 
of 3D printed polymers. However, despite apparent reductions in transcription levels, CYP1A2 
remained significantly up regulated within Clear-FL (P = 0.003) and VeroClear (P ≤ 0.0005) polymer 
leachate (Figure. 6 D).  
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Figure.6. Morphological staining for albumin (green) and nucleic DNA (blue) of HepG2 cells cultured on (a) and within 
chemical leachate (b) of 3D printed polymer scaffolds; Clear-FLGPCL02 (Clear-FL), PA-12 and VeroClear-RGD810 
(VeroClear). Albumin fluorescent staining could not be presented in direct conditions due to high auto-fluorescence evident 
in response to the Alex-Fluor488 fluorochrome, with Clear-FL also highly auto-fluorescent in response to multiple nuclear 
fluorochromes.  Cytochrome P450 expression of HepG2 cultured on (c) and within chemical leachate (d) of 3D printed 
polymers at 96 h time-point. Significantly different from * control. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.0005. Scale bars = 
100 µm. 
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4. Discussion 
Understanding the cellular physiological interaction with the physical/physico-chemical properties of 
3D printed polymers is of critical importance. Particularly when evaluating the specific AM process 
and polymer combination while creating physiologically representative in vitro models,[28–31] that are 
utilised within tissue engineering and or pharmaceutical screening applications. This research 
demonstrates cell type specific biocompatibility across a range of industry standard 3D printing 
techniques; SL, LS and PolyJet, for incorporation within tissue engineering models of 
musculoskeletal[32] and neurological disorders,[33] in addition to pharmacological screening systems.[37] 
In this work we used C2C12, SH-SY5Y and HepG2 cell lines in order to ascertain critical evidence of 
cellular behaviour in response to 3D printed candidate polymers due to their capacity to afford a range 
of optically transparent (Clear-FL and VeroClear) and bio-inert (PA-12) parts from commercially 
available and accessible AM instrumentation.  
Whilst the chemical compositions of these polymers (specifically Clear-FL and VeroClear) are often 
commercially protected proprietary material formulations, it is possible to determine the general 
characteristics of these materials. UV curable photo-polymers are typically based on acrylates, 
epoxides and urethanes with the final material likely to be densely crosslinked.[43] Specifically, the 
Clear-FL resin contains a proprietary mixture of methacrylate oligomers and monomers, as well as a 
photoinitiator.[44] VeroClear resin contains acrylic monomer (<30%), acrylic oligomer (<15%), 
isobornyl acrylate (<25%), photoinitiator (<2%) and acrylic acid ester (<0.3%).[45] The composition of 
both the uncured liquid resins and chemically leached components for both Clear-FL and VeroClear 
were assessed via Nuclear Magnetic Resonance spectroscopy (NMR, Figure. S2 and S4 
supplementary material) and Fourier Transform Infra-Red spectroscopic analysis (FTIR, Figure. S3 
and S5 supplementary material). When analysing the uncured liquid Clear-FL resin via NMR, 
characteristic peaks were observed suggesting the presence of C=C (5.5-6.25 ppm), RCH3 (4.35ppm) 
as well as primary, secondary and tertiary aliphatic (1-2ppm) functionality within the materials. Each 
of these peaks remained present in the leached material, indicating uncured methacrylate oligomers 
and monomers constitutes the major leachate component. This hypothesis is further supported via 
FTIR analysis of Clear-FL resin and leachate, both indicating the presence of –OH (3370cm-1, 
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stretch), C-H (2950cm-1, stretch), C=O (1700-1720 cm-1, stretch), as well as C=C (1637cm-1, stretch) 
identifying acrylate functionality within the sample. NMR analysis of uncured liquid VeroClear resin 
outlined presence of primary, secondary and tertiary aliphatic (0.7-1.2 ppm), RCH2 (1.25-2 ppm), 
RCH3 (3.7 ppm) and C=C (5.5-6.5 ppm) indicating functionality typically associated with the 
presence of acrylic monomers, oligomers, isobornyl acrylates and acrylic acid esters. However, a 
reduction in methyl terminated esters was apparent whilst retaining characteristic acrylate 
functionality. This indicates a reduced presence of either the acrylic monomer or oligomer within the 
leachate samples. Further functional characterisation was achieved via FTIR, with characteristic peaks 
indicating the presence of =C-H (2953cm-1, stretch), C=O (1718cm-1, stretch), C=C (1643cm-1, 
stretch) observed in both uncured resin and printed samples. 
It is generally assumed that printed samples are densely crosslinked upon removal from their 
respective printers. Despite this, differences in the final solid state of printed parts may also be 
attributed to methods of resin curing. Whilst not typical, UV or thermal post-curing of PolyJet printed 
parts is employed to enhance the physical properties of finished parts for certain materials. The 
manufacturers of SL processes typically recommend employing UV post-curing of printed parts. This 
would indicate incomplete monomer crosslinking within the printed parts. SL uses dynamic mirrors to 
direct UV lasers towards a vat of uncured liquid resin. Whereas PolyJet deposits uncured resin layer 
by layer onto the build platform via multiple print heads, with the polymer being cured as it is 
deposited using UV lamps. Lasers utilised in SL are very specific in wavelength, highly accurate in 
position, but are often lower in power compared to UV lamps used within PolyJet printing processes. 
These lamps also have a wider spread of wavelengths emitted. In addition, in SL the scan strategy 
(pattern) described by the laser for each layer can be altered to improve accuracy and or speed.  As 
such, the final solid state of SL printed parts will be dependent on a combination of the print settings 
(scan pattern, layer thickness, etc.), curing process, type of resin and specific machine. Data observed 
within NMR analyses indicated that compounds containing acrylate functionality (Clear-FL and 
VeroClear photo-polymers) appear to be the major component of leached compounds during the 
solvent extraction affecting the cell lines used. This indicates potentially incomplete crosslinking of 
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monomer resin during the printing process. Adverse biological outputs upon the cell lines tested are 
likely a combination of not only the original chemical composition, but also the amount of such 
compounds being leached into the cellular medium. Cytotoxic effects of methacrylate monomers and 
oligomers have been previously reported in the literature. This is attributed to the induction of 
apoptosis, genotoxicity and cell cycle arrest.[46] Further work has speculated that such toxicity may 
also be related to the generation of reactive oxygen species (ROS) within cell cultures.[47] Structure 
toxicity relationships have also observed inverse correlation between cellular toxicity and compound 
lipophilicity, with the mechanism of these compounds likely membrane mediated.[48] This response 
can however be reduced, and/or ameliorated through solvent extraction prior to cellular interaction as 
reported in this work. 
It is possible that specific machine parameters and/or forms of UV or possibly thermal post-curing 
might improve the degree of complete crosslinking in 3D printed parts, which might in turn reduce the 
leaching of cytotoxic compounds. This is particularly the case in SL where there are more parameters 
that could be easily varied. For example, slower scan strategies with greater overlap of laser paths and 
thinner layers might ensure higher degrees of crosslinking during printing, with the compromise being 
much slower build speeds and potentially poorer dimensional accuracy. Certain special resins in 
PolyJet and SL already require thermal and or UV post-curing to achieve enhanced physical 
properties and these techniques could be explored to ensure a greater level of crosslinking. The 
improvements in physical properties, typically stiffness or toughness suggests that the post-curing 
does indeed lead to higher degrees of crosslinking. Future work should seek to investigate the effects 
of machine parameters and post-curing techniques on the leaching of toxic compounds.  
Metabolic activity of C2C12 skeletal myoblasts cultured on VeroClear and PA-12 polymer scaffolds 
appeared to produce viable cultures within proliferation and differentiation phases, demonstrating 
evidence of initial cellular compatibility. Although cell cultures within scaffolds were significantly 
less metabolically active than in control conditions, this is often a consequence of the non-uniform 
polymer surfaces created by the AM processes. However, significant decrements in Clear-FL and 
VeroClear cellular viability observed coincided with reductions in myotube number, fusion index and 
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MYH3 expression, outlining inhibition of myogenic differentiation and skeletal muscle maturation, 
despite comparable myotube widths. Such reductions were however not evident when cells were 
cultured on PA-12 scaffolds, with comparable morphological and transcriptional phenotypes evident. 
This further outlines the applicability of this polymer and favourability of LS when fabricating 
scaffolds for musculoskeletal tissue engineering applications.[28,29,33] 
Reductions observed in cellular viability were however completely ameliorated in C2C12 cells exposed 
to chemical leachate of all 3D printed polymers at proliferative and differentiation time-points, 
outlining viable levels of metabolic activity in all conditions. Morphological parameters of skeletal 
muscle cellular phenotype remained consistent to that of control conditions in Clear-FL and PA-12 
polymer leachate. However, reductions in myotube number and subsequent reductions in fusion 
efficiency evident in VeroClear conditions suggests an inhibitory effect of this polymer leachate on 
C2C12 myogenic differentiation, yet while retaining the proliferative capacity of this population. 
Transcriptional MYH3 regulation was statistically reduced compared to control, however substantial 
increases between direct and indirect Clear-FL and Vero-Clear conditions were apparent; further 
outlining the phenotypic recovery evident when exposed to chemical polymer leachate, as opposed to 
the physico-chemical characteristics of each polymer. Despite reduced MYH3 expression, 
morphological and metabolic indices outline viable cultures of in vitro skeletal muscle in both Clear- 
FL and PA-12 conditions.   
Viable cultures of neuronal SH-SY5Y cells were also evident when cultured on PA-12 polymer 
scaffolds at proliferative and differentiated time-points, however SH-SY5Y cells displayed 
diminished viability within Clear-FL and VeroClear conditions at GM48 and DM72 h time-points, 
outlining inhibition of cellular proliferation when cultured on 3D printed photo-polymer scaffolds. 
Despite the significant decrements in metabolic activity observed, MAPT transcriptional activation 
remained consistent across PA-12 and Vero-Clear conditions, suggesting comparable levels of neurite 
extension despite reduced proliferation in VeroClear conditions. 
Restoration of SH-SY5Y cellular viability was evident in cells cultured in VeroClear chemical 
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leachate. However, levels of metabolic activity and nuclei number remained suppressed in Clear-FL 
conditions. Despite evident reductions in proliferation, significantly enhanced neurite lengths were 
observed in Clear-FL leachate conditions. This response was replicated in part when cells were 
cultured in VeroClear chemical leachate, which also demonstrated significantly potentiated neurite 
extension in culture. MAPT gene expression remained consistent with control levels in Clear-FL, 
suggesting contrasting cultures of abundant neuronal extension at the cost of reduced neurite length, 
compared to sparse cellular populations of enhanced neurite growth, indicating potentiated neuronal 
extension of SH-SY5Y in environments of reduced cellular confluence.[49] Further speculative support 
for the aforementioned notion is evident, with neurite lengths and MAPT expression increasing in 
conjunction with decreasing levels of metabolic activity in both PA-12 and VeroClear conditions.  
Despite apparent biologically representative values in PA-12 conditions, significant reductions were 
evident in HepG2 cellular viability when cultured on 3D printed scaffolds, with VeroClear and Clear-
FL photo-polymers eliciting near complete ablation of cellular viability. Morphological HepG2 
nuclear number further supports this assertion, with reductions evident in VeroClear conditions. 
Despite reduced nuclear number reported in PA-12 polymer scaffolds, when taken in context with 
biologically comparable metabolic activity, is likely a consequence of microscopic distortion with 
cells and particles coexisting within different frames of the Z axis. Cytochrome P450 enzymatic 
transcription was significantly up-regulated in response to 96 h culture on Clear-FL and VeroClear 
polymer scaffolds across CYP1A1, 1A2 and 2D6 isoforms, outlining physico-chemical interference 
within HepG2 cellular metabolism. PA-12 polymer scaffolds elicited statistically comparable 
cytochrome P450 expression to that seen in control conditions, suggesting reduced influence of this 
polymer on CYP1A1, 1A2, 2D6 and 3A4 transcription. 
HepG2 cells cultured in PA-12 chemical leachate demonstrated complete recovery and displayed 
comparative metabolic activity and nuclear number to control conditions; however, cells cultured in 
Clear-FL remained significantly reduced in number despite evident biological restoration. This 
response was in part replicated in VeroClear conditions, demonstrating reduced proliferation during 
intermediate time-points. However, cell number appeared to recover after 96 h in culture. Despite 
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reductions in proliferation observed in Clear-FL, cytochrome P450 expression levels were restored to 
basal levels in CYP1A1, 2D6 and 3A4 isoforms across polymers. Although comparable levels to 
control were observed in PA-12 chemical leachate, CYP1A2 remained significantly up regulated in 
Clear-FL and VeroClear conditions. Despite significant transcriptional upregulation evident in 
CYP1A2, such values remained physiologically comparable, with increases in HepG2 cytochrome 
P450 expression confined to ≤ 1-fold.  
The integration of 3D printing within biological systems holds significant potential when redefining 
the methods utilised for the creation of scaffolds and in vitro models. Specifically, those that comprise 
complex cellular physiological processes. To exploit such advances in AM technology, biological 
facets of polymer compatibility must be considered in addition to the evaluation of design 
requirements and 3D printing process parameters. This research demonstrates initial critical evidence 
for a framework of polymer/process selection, with C2C12, SH-SY5Y and HepG2 cells favouring LS 
polymer PA-12 for applications in which cellular adherence is necessitated. Biocompatible responses 
observed in PA-12 are likely due to the pure formulation and manufacturing of this polymer. PA-12 
3D printed via LS as evidenced within this work is consolidated using a high-powered laser, requiring 
no additional chemical compounds to create 3D structures. This is opposed to the laser/UV lamp 
polymerisation of complex photo-polymers seen in SL and PolyJet. The solubility of PA-12 is also 
low. This results in surfaces of reduced chemical complexity and parts that do not contain small 
molecules to leach. Scaffolds for in vitro systems often comprise simplistic designs due to the 
rudimentary methods previously utilised.[29] The design flexibility afforded by LS provides the 
capability to rapidly produce, and reproduce multiple design iterations of such models. Although 
currently limited by the broad accessibility of this technology, recent developments have seen a trend 
toward commercialisation, with desktop LS printers becoming commercially accessible.[50] 
Enhanced polymer/process flexibility was observed when examining the chemical leachate of SL and 
PolyJet photo-polymers, with cell type specific responses evident. Despite reduced cellular responses 
to SL Clear-FL and PolyJet VeroClear resins in the direct condition, physiologically relevant 
morphological and transcriptional profiles were documented in leachate conditions. Such responses 
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may present the opportunity to utilise these materials within devices in which cell/polymer interaction 
is confined to leachates within the culture medium. Pertinent to this are bespoke perfusion systems[7,51] 
and microfluidic devices,[11] that are currently being utilised for the examination and recreation of 
musculoskeletal and neurological cellular physiological processes in vitro.[22,52] The homogeneity of 
cytochrome P450 enzymatic activity across SL, LS and PolyJet AM processes, may also afford the 
opportunity to produce 3D printed fluidic devices that contain multiple cell types (Table 2). 
Table 2 
Biocompatibility of 3D printed polymers. – Non-biocompatible; * supports proliferation; Ψ supports 
differentiation; # supports physiological Cytochrome P450 expression. Completely biocompatible, 
experiment specific compatibility, non-biocompatible. 
 
Microfluidic systems concerned with the creation of ‘organ on a chip’ devices[22,52,53] often require 
intricate design features that necessitate photo-polymerisation processes such as SL and PolyJet. This 
is primarily due to consolidation variability of sintered particles within LS designs, often preventing 
the removal of un-sintered material from micron-sized features.[43] As such, although LS PA-12 
provides bio-inert polymers for scaffolds necessitating cellular adherence, SL and PolyJet resins may 
be favoured for perfusion/screening devices dependent on cell line selection and desired phenotype. 
Work has been undertaken where bespoke biocompatible SL resins have been synthesised,[54] however 
due to a lack of commercial availability, such research is currently limited in its translation to the 
wider scientific community. This further outlines the significance of readily available biocompatible 
AM Process 
Direct Biocompatibility Indirect Biocompatibility 
C2C12 SH-SY5Y HepG2 C2C12 SH-SY5Y HepG2 
Stereolithography * - - * Ψ Ψ # 
PolyJet * Ψ - * * Ψ # 
Selective Laser 
Sintering * Ψ * Ψ # * Ψ * Ψ * # 
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photo-polymers elucidated within this work, specifically when aspiring to 3D print musculoskeletal, 
neurological and or pharmacological compatible systems. 
5. Conclusions 
This investigation observed cell type specific biocompatibility across three industry standard 3D 
printing processes, which affords the opportunity for experiment-specific 3D printing process and 
polymer selection; dependent on desired biological application and necessitated design feature 
intricacy. To fully exploit AM technology within bioengineering systems, future work should seek to 
develop a broad range of compatibility data derived from commercially available and accessible 3D 
printing processes, across a diverse variety of mammalian cell types. Further work should also be 
undertaken to investigate the printing parameters and post-curing techniques of photo-polymerised 
resins. By manipulating these variables, it may be possible to further minimise the leaching of toxic 
compounds, with a view to also reducing the time required to reach biologically compatible levels.  
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Table S1 - Details regarding experimental adherence to ISO10993 protocol.  
ISO 10993 Guideline Experimental Condition 
Sample to be preconditioned by the same 
processing steps as the final intended product 
Experimental protocol intended to be 
reproducible for part designs of more 
complex geometries and therefore a suitable 
methodology for “final products”  
The fluid used for extraction and the extraction 
conditions should be appropriate to the final device 
and its end use. 
The fluid used for extraction (cell culture 
growth media) was the ideal solvent with 
which to undertake the extraction as the final 
intended use of the material was cell culture 
applications.   
Extraction should contain both an organic and 
aqueous solvent 
Parts were washed with both IPA (mild 
organic solvent selected to prevent part 
damage) as well as aqueous growth media 
Temperature of extraction should be high enough to 
maximise extraction without damaging the part 
Extraction carried out at 37 °C to mimic 
culture environment, whilst not causing 
damage to photopolymers with low glass 
transition temperatures. 
Ideally extraction carried out under static 
conditions 
Static conditions used 
For synthetic polymers material thickness should be 
between 0.5 and 1 mm in thickness 
Material was 1mm in thickness 
For synthetic polymers surface area to volume ratio 
for extraction should be 3cm2 per ml. 
Surface area to volume ratio for extraction 
utilised was 3cm2 per ml. 
Appropriate reference materials utilised throughout 
experiment to provide both a positive and negative 
control  
Tissue culture plastic used as a negative 
control; however it was not considered of 
interest to include a positive control whereby 
cellular death would be prevalent, offering 
limited measurable or novel data. 
 
  
Figure. S1. (a) 3D printed samples via stereolithography (Clear-FL), polyjet (VeroClear) and selective laser sintering (PA-12). (b) VeroClear 
samples during 10 day incubation within 5 ml growth medium. Scale bar = 10 mm. 
 
 Figure. S2. Nuclear magnetic resonance (NMR) spectra for (A) FormlabsTM Clear-FLGPCL02 resin and 
(B) leachate from printed samples. Characteristic peaks include; 1H NMR (42.5 MHz; CDCl3, ppm) δ 1-2 
(m, aliphatic, both spectra), 4.4 (s, 3H, CH3, both spectra), 5.6 (t, 1H, CH, both spectra), 6.2 (t, 1H, CH, 
both spectra).  
 
  
 
 
 
 
Figure. S3. Infrared (IR) spectra for (A) FormlabsTM Clear-FLGPCL02 resin and (B) leachate from printed samples. 
Characteristic peaks include (cm-1); ν 3370 (-OH, stretch, both spectra), 2955 (C-H, stretch, both spectra), 1700-1720 (C=O, 
stretch, both spectra), 1637 (C=C, stretch, both spectra). 
 
 Figure. S4. Nuclear magnetic resonance (NMR) spectra for (A) PolyJet VeroClear-RGD810 resin and (B) leachate 
from printed samples. Characteristic peaks include; 1H NMR (42.5 MHz; CDCl3, ppm) δ 0.7-2 (m, aliphatic, both 
spectra), 3.7 (s, 3H, CH3, both spectra), 5.5-6.5 (m, CH, A only), 5.8 (t, 1H, CH, both spectra), 6.2 (t, 1H, CH, both 
spectra). 
  
 
 
 
 
Figure. S5. Infrared (IR) spectra for (A) PolyJet VeroClear-RGD810 resin and (B) leachate from printed samples. 
Characteristic peaks include (cm-1); 2955 (C-H, stretch, both spectra), 1720 (C=O, stretch, both spectra), 1640 (C=C, stretch, 
A only). 
 
